UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 86

Sortiert nach

A Third Shot at EGFR: New Opportunities in Cancer Therapy

Trends in pharmacological sciences (Regular ed.), 2019-12, Vol.40 (12), p.941-955

2019

Volltextzugriff (PDF)

Probing the Kinetic and Thermodynamic Fingerprints of Anti-EGF Nanobodies by Surface Plasmon Resonance

Pharmaceuticals (Basel, Switzerland), 2020-06, Vol.13 (6), p.134

2020

Volltextzugriff (PDF)

Combating virulence of Gram-negative bacilli by OmpA inhibition

Scientific reports, 2017-10, Vol.7 (1), p.14683-11, Article 14683

2017

Volltextzugriff (PDF)

Toward a Novel Drug To Target the EGF–EGFR Interaction: Design of Metabolically Stable Bicyclic Peptides

Chembiochem : a European journal of chemical biology, 2018-01, Vol.19 (1), p.76-84

2018

Volltextzugriff (PDF)

Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons

Proceedings of the National Academy of Sciences - PNAS, 2018-10, Vol.115 (41), p.10481-10486

2018

Volltextzugriff (PDF)

A new synthetic protegrin as a promising peptide with antibacterial activity against MDR Gram-negative pathogens

Journal of antimicrobial chemotherapy, 2022-10, Vol.77 (11), p.3077-3085

2022

Volltextzugriff (PDF)

Enthalpy‐ versus Entropy‐Driven Molecular Recognition in the Era of Biologics

Chembiochem : a European journal of chemical biology, 2019-12, Vol.20 (24), p.2981-2986

2019

Volltextzugriff (PDF)

In vivo photocontrol of orexin receptors with a nanomolar light-regulated analogue of orexin-B

Cellular and molecular life sciences : CMLS, 2024-12, Vol.81 (1), p.288, Article 288

2024

Volltextzugriff (PDF)

Abstract 1839: Nanobodies against EGF enhance the antitumoral effect of osimertinib and overcome resistance in non-small cell lung cancer cell models

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1839-1839

2021

Volltextzugriff (PDF)

Target-templated de novo design of macrocyclic d -/ l -peptides: discovery of drug-like inhibitors of PD-1

Chemical science (Cambridge), 2021-03, Vol.12 (14), p.5164-5170

2021

Volltextzugriff (PDF)

Anti-EGF nanobodies enhance the antitumoral effect of osimertinib and overcome resistance in non-small cell lung cancer (NSCLC) cellular models

Medical oncology (Northwood, London, England), 2022-09, Vol.39 (12), p.195-195, Article 195

2022

Volltextzugriff (PDF)

Targeted Covalent Inhibition of Prolyl Oligopeptidase (POP): Discovery of Sulfonylfluoride Peptidomimetics

Cell chemical biology, 2018-08, Vol.25 (8), p.1031-1037.e4

2018

Volltextzugriff (PDF)

From venoms to BBB-shuttles. MiniCTX3: a molecular vector derived from scorpion venom

Chemical communications (Cambridge, England), 2018-11, Vol.54 (90), p.12738-12741

2018

Volltextzugriff (PDF)

From venoms to BBB-shuttles. MiniCTX3: a molecular vector derived from scorpion venomElectronic supplementary information (ESI) available: Experimental procedures and supplementary figures and tables. See DOI: 10.1039/c8cc06725b

2018-11

Volltextzugriff (PDF)

Synthesis and antiviral evaluation of bisnoradamantane sulfites and related compounds

Medicinal chemistry (Shp-sariqah, United Arab Emirates), 2011-03, Vol.7 (2), p.135

2011

Volltextzugriff (PDF)

Blocking EGFR Activation with Anti‐EGF Nanobodies via Two Distinct Molecular Recognition Mechanisms

Angewandte Chemie International Edition, 2018-10, Vol.57 (42), p.13843-13847

International ed. in English, 2018

Volltextzugriff (PDF)

Proteomic Tools for the Quantitative Analysis of Artificial Peptide Libraries: Detection and Characterization of Target‐Amplified PD‐1 Inhibitors

Chembiochem : a European journal of chemical biology, 2022-06, Vol.23 (12), p.e202200152-n/a

2022

Volltextzugriff (PDF)

Protein Chemical Synthesis Combined with Mirror‐Image Phage Display Yields d‐Peptide EGF Ligands that Block the EGF–EGFR Interaction

Chembiochem : a European journal of chemical biology, 2019-08, Vol.20 (16), p.2079-2084

2019

Volltextzugriff (PDF)

Peptides Targeting EGF Block the EGF-EGFR Interaction

Chembiochem : a European journal of chemical biology, 2016-04, Vol.17 (8), p.702-711

2016

Volltextzugriff (PDF)

Combating virulence of Gramnegative bacilli by OmpA inhibition

Scientific reports, 2017-10

2017

Volltextzugriff (PDF)

Combating virulence of Gramnegative bacilli by OmpA inhibition

Scientific reports, 2017-10

2017

Volltextzugriff (PDF)

Combating virulence of Gramnegative bacilli by OmpA inhibition

Scientific reports, 2017-10

2017

Volltextzugriff (PDF)

Cover Picture: Peptides Targeting EGF Block the EGF-EGFR Interaction (ChemBioChem 8/2016)

Chembiochem : a European journal of chemical biology, 2016-04, Vol.17 (8), p.642-642

2016

Volltextzugriff (PDF)

Blocking EGFR Activation with Anti‐EGF Nanobodies via Two Distinct Molecular Recognition Mechanisms

Angewandte Chemie, 2018-10, Vol.130 (42), p.14039-14043

2018

Volltextzugriff (PDF)

Target-templated design of macrocyclic -/-peptides: discovery of drug-like inhibitors of PD-1

Chemical science (Cambridge), 2021-04, Vol.12 (14), p.5164-517

2021

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(83)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A Third Shot at EGFR: New Opportunities in Cancer Therapy

Probing the Kinetic and Thermodynamic Fingerprints of Anti-EGF Nanobodies by Surface Plasmon Resonance

Combating virulence of Gram-negative bacilli by OmpA inhibition

Toward a Novel Drug To Target the EGF–EGFR Interaction: Design of Metabolically Stable Bicyclic Peptides

Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons

A new synthetic protegrin as a promising peptide with antibacterial activity against MDR Gram-negative pathogens

Enthalpy‐ versus Entropy‐Driven Molecular Recognition in the Era of Biologics

In vivo photocontrol of orexin receptors with a nanomolar light-regulated analogue of orexin-B

Abstract 1839: Nanobodies against EGF enhance the antitumoral effect of osimertinib and overcome resistance in non-small cell lung cancer cell models

Target-templated de novo design of macrocyclic d -/ l -peptides: discovery of drug-like inhibitors of PD-1

Anti-EGF nanobodies enhance the antitumoral effect of osimertinib and overcome resistance in non-small cell lung cancer (NSCLC) cellular models

Targeted Covalent Inhibition of Prolyl Oligopeptidase (POP): Discovery of Sulfonylfluoride Peptidomimetics

From venoms to BBB-shuttles. MiniCTX3: a molecular vector derived from scorpion venom

From venoms to BBB-shuttles. MiniCTX3: a molecular vector derived from scorpion venomElectronic supplementary information (ESI) available: Experimental procedures and supplementary figures and tables. See DOI: 10.1039/c8cc06725b

Synthesis and antiviral evaluation of bisnoradamantane sulfites and related compounds

Blocking EGFR Activation with Anti‐EGF Nanobodies via Two Distinct Molecular Recognition Mechanisms

Proteomic Tools for the Quantitative Analysis of Artificial Peptide Libraries: Detection and Characterization of Target‐Amplified PD‐1 Inhibitors

Protein Chemical Synthesis Combined with Mirror‐Image Phage Display Yields d‐Peptide EGF Ligands that Block the EGF–EGFR Interaction

Peptides Targeting EGF Block the EGF-EGFR Interaction

Combating virulence of Gramnegative bacilli by OmpA inhibition

Combating virulence of Gramnegative bacilli by OmpA inhibition

Combating virulence of Gramnegative bacilli by OmpA inhibition

Cover Picture: Peptides Targeting EGF Block the EGF-EGFR Interaction (ChemBioChem 8/2016)

Blocking EGFR Activation with Anti‐EGF Nanobodies via Two Distinct Molecular Recognition Mechanisms

Target-templated design of macrocyclic -/-peptides: discovery of drug-like inhibitors of PD-1

Suchergebnisse filtern